Cell Therapeutics Announces Commercial Launch Of Pixuvri In EU - Quick Facts

Cell Therapeutics Q1 13 Earnings Conference Call At 4:30 PM ET

Cell Therapeutics Inks $15 Mln Loan Agreement With Hercules Technology

Cell Therapeutics To Present At ROTH Capital Conference; Webcast At 5:30 PM ET

Trade CTIC now with

9/11/2012 1:41 AM ET

Cell Therapeutics, Inc. (CTIC: Quote) Tuesday announced the initiation of the commercial launch of Pixuvri in the European Union.

While the drug will enter Sweden, Denmark and Finland in September, it will be launched in Austria and Norway in early October and Germany, United Kingdom and the Netherlands in November. CTI plans to expand availability to France, Italy and Spain as well as other European countries in 2013.

Pixuvri was granted conditional marketing authorization by the European Commission in May and is the first medicinal product licensed in the E.U. to treat adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin Lymphoma or NHL. In the E.U., there are around 37,000 new cases of aggressive B-cell NHL every year.

Click here to receive FREE breaking news email alerts for Cell Therapeutics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 133 Articles

Editors Pick

Gap Profit Climbs 43%

Gap Inc. Thursday after the markets closed that its first quarter profit rose 43% from last year, helped by higher sales and improved margins. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company eaffirmed its fiscal year 2013 earnings outlook, which is below analysts' current consensus estimate.

Stocks Close Modestly Lower But Well Off Worst Levels - U.S. Commentary

After moving sharply lower at the start of trading on Thursday, stocks showed a substantial recovery attempt over the course of the trading day. The rebound came as upbeat housing data helped offset worries about the Federal Reserve. The major averages climbed well off their worst levels of the day but still ended the session in the red.

Obama Outlines Counterterrorism Policy To Confront Shifting Threats

President Barack Obama delivered a highly-anticipated speech on his administration's evolving counterterrorism policies on Thursday, suggesting that the U.S. needs to move away from a "boundless global war on terror." More than a decade after the 9/11 attacks, Obama argued that the terrorist threat has shifted and evolved.